Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2013 by Seoul National University Hospital.
Recruitment status was  Recruiting
Astellas Pharma Korea, Inc.
Information provided by (Responsible Party):
Dong Ki Kim, Seoul National University Hospital Identifier:
First received: February 19, 2013
Last updated: December 13, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):